Cargando…

Present and future of secondary prevention after an acute coronary syndrome

Despite a marked improvement of in-hospital outcome of patients with Acute Coronary Syndrome (ACS), long-term outcome remains poor. There remains a high risk of complications, Non ST-Elevation ACS (NSTE-ACS) patients being at higher risk than those with ST-elevation ACS, in part due to more diffuse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Keller, Pierre-Frederic, Carballo, Sebastian, Carballo, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2011
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3405406/ https://www.ncbi.nlm.nih.gov/pubmed/23199175 http://dx.doi.org/10.1007/s13167-011-0129-3

Ejemplares similares

Clinical impact of a structured secondary cardiovascular prevention program following acute coronary syndromes: A prospective multicenter healthcare intervention
por: Carballo, David, et al.
Publicado: (2019)

Acute Respiratory and Cardiovascular Admissions after a Public Smoking Ban in Geneva, Switzerland
por: Humair, Jean-Paul, et al.
Publicado: (2014)

Quality of Care after Acute Coronary Syndromes in a Prospective Cohort with Reasons for Non-Prescription of Recommended Medications
por: Auer, Reto, et al.
Publicado: (2014)

Update to Evidence-Based Secondary Prevention Strategies After Acute Coronary Syndrome
por: Fitchett, David H., et al.
Publicado: (2020)

New Antithrombotics for Secondary Prevention of Acute Coronary Syndrome
por: Goto, Shinya, et al.
Publicado: (2014)

Oral Antiplatelet Therapy for Secondary Prevention of Acute Coronary Syndrome
por: Berger, Jeffrey S.
Publicado: (2018)

Prognosis of cardiovascular and non-cardiovascular multimorbidity after acute coronary syndrome
por: Canivell, Silvia, et al.
Publicado: (2018)

Secondary Cardiovascular Prevention after Acute Coronary Syndrome: Emerging Risk Factors and Novel Therapeutic Targets
por: Silverio, Angelo, et al.
Publicado: (2023)

Eligibility for PCSK9 Inhibitors According to American College of Cardiology (ACC) and European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) Guidelines After Acute Coronary Syndromes
por: Gencer, Baris, et al.
Publicado: (2017)

Eligibility for sacubitril–valsartan in patients with acute decompensated heart failure
por: Carballo, David, et al.
Publicado: (2020)

DELAYED PRESENTATION OF ACUTE CORONARY SYNDROME SECONDARY TO COVID-19
por: SHAKERIAN, B., et al.
Publicado: (2022)

Use of medicines recommended for secondary prevention of acute coronary syndrome
por: Gaedke, Mari Ângela, et al.
Publicado: (2015)

Changing the Landscape of Secondary Prevention After Acute Coronary Syndrome: Morphology, Physiology, or Both?
por: Otake, Hiromasa
Publicado: (2022)

Antithrombotic therapy for long-term secondary prevention of acute coronary syndrome in high-risk patients
por: Husted, Steen
Publicado: (2015)

Non-Linear Relationship between Anti-Apolipoprotein A-1 IgGs and Cardiovascular Outcomes in Patients with Acute Coronary Syndromes
por: Vuilleumier, Nicolas, et al.
Publicado: (2019)

Iron Deficiency in Acute Decompensated Heart Failure
por: Beale, Anna, et al.
Publicado: (2019)

Use of Secondary Prevention Drug Therapy in Patients With Acute Coronary Syndrome After Hospital Discharge
por: Lee, Helen Y., et al.
Publicado: (2008)

Secondary prevention therapies in acute coronary syndrome and relation to outcomes: observational study
por: Chow, Clara K, et al.
Publicado: (2019)

Prognostic Value of the Echocardiographic Probability of Pulmonary Hypertension in Patients with Acute Decompensated Heart Failure
por: Carballo, Sebastian, et al.
Publicado: (2019)

Increased mortality after a first myocardial infarction in human immunodeficiency virus-infected patients; a nested cohort study
por: Carballo, David, et al.
Publicado: (2015)

Biomarkers and arrhythmia recurrence following radiofrequency ablation of atrial fibrillation
por: Carballo, David, et al.
Publicado: (2018)

Risks and benefits of urinary catheterisation during inpatient diuretic therapy for acute heart failure: a retrospective, non-inferiority, cohort study
por: John, Gregor, et al.
Publicado: (2022)

Cost-effectiveness Analysis of Rivaroxaban in the Secondary Prevention of Acute Coronary Syndromes in Sweden
por: Begum, Najida, et al.
Publicado: (2015)

Evaluation of discharge prescriptions for secondary prevention in patients with acute coronary syndromes in Iraq
por: Nassr, Ola A., et al.
Publicado: (2019)

Acute Coronary Syndrome Secondary to Aortocaval Fistula
por: Cruz-Utrilla, Alejandro, et al.
Publicado: (2019)

Early Discharge in Low-Risk Patients Hospitalized for Acute Coronary Syndromes: Feasibility, Safety and Reasons for Prolonged Length of Stay
por: Laurencet, Marie-Eva, et al.
Publicado: (2016)

ApoA-I Infusion Therapies Following Acute Coronary Syndrome: Past, Present, and Future
por: Kalayci, Arzu, et al.
Publicado: (2022)

Effect and safety of antithrombotic therapies for secondary prevention after acute coronary syndrome: a network meta-analysis
por: Mo, Fanrui, et al.
Publicado: (2018)

High Risk Features of an Anomalous Origin of the Right Coronary Artery
por: Campiche, Dre Eleonore, et al.
Publicado: (2021)

Adherence to guidelines for the prescription of secondary prevention medication at hospital discharge after acute coronary syndrome: a multicentre study
por: Tra, J., et al.
Publicado: (2015)

Prevention after acute coronary syndrome the ‘less is more’ philosophy
por: Temporelli, Pier Luigi
Publicado: (2020)

Smartphone Applications to Support Tuberculosis Prevention and Treatment: Review and Evaluation
por: Iribarren, Sarah J, et al.
Publicado: (2016)

Revisiting secondary prevention in coronary heart disease
por: Sigamani, Alben, et al.
Publicado: (2022)

Are there gender differences in acute management and secondary prevention of acute coronary syndromes in Barbados? A cohort study
por: Sobers, Natasha, et al.
Publicado: (2019)

Acute Myocarditis Presenting as Acute Coronary Syndrome
por: Mosebach, Christian M, et al.
Publicado: (2019)

Evidence of poor adherence to secondary prevention after acute coronary syndromes: possible remedies through the application of new technologies
por: Cheng, Kevin, et al.
Publicado: (2015)

Clinical Practice Guideline for Cardiac Rehabilitation in Korea: Recommendations for Cardiac Rehabilitation and Secondary Prevention after Acute Coronary Syndrome
por: Kim, Chul, et al.
Publicado: (2019)

eHealth Interventions for HIV Prevention in High-Risk Men Who Have Sex With Men: A Systematic Review
por: Schnall, Rebecca, et al.
Publicado: (2014)

The effects of secondary prevention after coronary revascularization in Taiwan
por: Feng, Wen-Han, et al.
Publicado: (2019)

Beyond COVID-19: the future of maritime transport
por: Carballo Piñeiro, Laura, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ln48jnq5gj62preu0q4dq0oo9c